StemRIM Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
StemRIM Inc. - overview
Established
2006
Location
Osaka, -, Japan
Primary Industry
Pharmaceuticals
About
Founded in 2006 and based in Osaka, Japan, StemRIM Inc. develops a substance of new drugs which can potentially cure intractable injuries and diseases.
Current Investors
Nippon Venture Capital, SMBC Venture Capital, Mizuho Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.stemrim.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
StemRIM Inc. - timeline of key events
StemRIM Inc. - financials
| Fiscal Year Ended | Jul 31, 2017 | Jul 31, 2018 | Jul 31, 2019 | Jul 31, 2020 | Jul 31, 2021 | Jul 31, 2022 |
|---|---|---|---|---|---|---|
| Revenue (USD) | - | 200,000,000 | 100,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | (50.0%) | - | - | - |
| EBITDA (USD) | - | (374,025,000) | (725,195,000) | - | - | - |
| Operating Income (USD) | - | (375,141,000) | (726,861,000) | - | - | - |
| Operating Margin | - | (187.6%) | (726.9%) | - | - | - |
| % EBITDA Margin | - | (187.0%) | (725.2%) | - | - | - |
| NET Income (USD) | (110,434,000) | (323,822,000) | (721,209,000) | - | - | - |
| % Net Margin | - | (161.9%) | (721.2%) | - | - | - |
StemRIM Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.